Are vaccines against COVID-19 tailored to the most vulnerable people?-Reference-Cited by-同舟云学术

Are vaccines against COVID-19 tailored to the most vulnerable people?

Published:2021-04 Issue:17 Volume:39 Page:2325-2327
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Antonelli Incalzi Raffaele,Trevisan Caterina^ORCID,Del Signore Susanna,Volpato Stefano,Fumagalli Stefano^ORCID,Monzani Fabio,Bellelli Giuseppe,Gareri Pietro^ORCID,Mossello Enrico^ORCID,Malara Alba,Coin Alessandra,Zia Gianluca,Ranhoff Anette Hylen

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference13 articles.

1. Immunosenescence and human vaccine immune responses;Crooke;Immun Ageing,2019

2. ICH topic E7 Studies in Support of Special Populations: Geriatrics Questions and Answers Step 5 European medicines Agency July 2010 EMA/CHMP/ICH/604661/2009 Committee for medicinal products for human use (CHMP) n.d. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e-7-studies-support-special-populations-geriatrics-questions-answers-step-5_en.pdf [accessed November 18, 2020].

3. Fluzone® High-Dose Influenza Vaccine;Robertson;Expert Rev Vaccines,2016

4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med,2020

5. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N Engl J Med,2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between COVID-19 vaccines and development of chronic morbidities: a cross-sectional study in the Jordanian population;Current Medical Research and Opinion;2024-01-09

2. Promoting and Building Long-Term Care Health Research Networks: GeroCovid Observational and Gerocovid Vax Initiatives;Journal of the American Medical Directors Association;2023-06

3. Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study;Internal and Emergency Medicine;2023-04-29

4. Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway;Vaccine;2023-01

5. Multimorbidity and Its Effect on Self-Reported Adverse Effects Following COVID-19 Vaccination;Cureus;2022-12-30